|
(11) | EP 2 111 394 A1 |
| (12) |
|
|
|
|
|||||||||||||||||||
| (54) | COMPOUNDS WITH A COMBINATION OF CANNABINOID-CB1 ANTAGONISM AND SEROTONIN REUPTAKE INHIBITION |